查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1923018

一次性血袋市場按產品類型、材質、配置、應用和最終用戶分類－2026-2032年全球預測

Single Use Blood Bag Market by Product Type, Material Type, Configuration, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，一次性血袋市場價值將達到 19.6 億美元，到 2026 年將成長至 20.7 億美元，到 2032 年將達到 30.6 億美元，年複合成長率為 6.57%。

關鍵市場統計數據
基準年 2025 19.6億美元
預計年份：2026年 20.7億美元
預測年份 2032 30.6億美元
複合年成長率 (%) 6.57%

簡明扼要、策略性地介紹一次性血袋技術、臨床需求、監管趨勢以及影響醫療服務提供者決策的採購重點。

本執行摘要介紹了一次性血袋市場，概述了臨床需求、材料科學的進展以及目前指導整個醫療保健系統採購決策的採購重點。過去十年，臨床醫生和供應鏈領導者日益關注生物相容性、病原體控制和人體工學操作等優先事項，這些因素正在影響產品選擇和供應商評估。原物料價格上漲和物流複雜性增加，加上臨床上為降低輸血相關風險所做的努力，共同創造了一個強調可追溯性和品管檢驗的採購環境。

對一次性血袋產業的變革性變化進行分析概述，包括材料創新、病原體減少趨勢以及供應鏈韌性的促進因素。

一次性血袋市場格局正經歷著變革性的轉變，其驅動力包括材料創新、病原體減少技術的應用以及為增強韌性而進行的全球供應鏈重組。非聚氯乙烯（PVC）聚合物科學和替代密封技術的進步緩解了人們對塑化劑的擔憂，使醫院能夠滿足更嚴格的生物相容性標準。同時，病原體減少系統和白血球去活化技術的改進提高了對血袋相容性的要求，迫使製造商和代工製造商重新設計流體接觸面和管路幾何形狀。

對目前和計劃中的關稅對美國供應鏈、籌資策略和一次性血袋臨床採購的累積影響進行詳細評估。

美國於2025年開始實施的關稅累積效應，為一次性血袋組件和成品的籌資策略帶來了新的複雜性。對進口聚合物、特殊管材和某些生產設備徵收的關稅，增加了依賴跨境原料的供應商的到岸成本，迫使許多公司重新評估其供應商基礎，並將近岸外包和在岸外包作為風險緩解策略。採購團隊正在透過與一級供應商簽訂長期契約，並將關稅轉嫁方案納入合約談判來應對這項挑戰。

按產品類型、材料、成分、最終用戶和應用進行細分，可提供關於臨床需求和採購路徑的詳細見解

細分市場分析揭示了不同產品類型、材料、配置、最終用戶和應用領域在臨床需求、生產複雜性和採購優先順序方面的細微差異。依產品類型分類，包括血漿袋、血小板袋、紅血球袋、特殊用途袋和全血袋。血漿袋有 250 毫升、300 毫升和 500 毫升三種規格，血小板袋則根據病原體減少和標準設計進行區分。紅血球袋有白血球去除和非白血球去除兩種選擇，全血袋則包括 CP2D、CPD 和 CPDA-1 配方。這些差異導致了不同的檢驗要求、輔料相容性測試和儲存條件要求。

區域情報：揭示美洲、歐洲、中東和非洲以及亞太市場的需求趨勢、監管差異和供應鏈優勢

區域趨勢影響著美洲、歐洲、中東和非洲以及亞太地區的監管要求、供應商集中度和籌資策略。在美洲，採購重點在於快速反應、區域製造夥伴關係關係以及與優先考慮病原體減少和可追溯性的臨床網路的合作。支付模式和醫院集團採購組織影響合約結構，以及從總體擁有成本 (TCO) 的角度出發，對高階功能的鼓勵程度。

競爭格局與公司層面洞察：重點在於產品系列、策略聯盟、製造地以及產業創新軌跡。

在一次性血袋領域，企業層面的定位主要集中在產品系列的廣度、製造地、夥伴關係模式和創新投資等方面。主要企業正在拓展產品組合，以支持病原體減少相容性、增強添加劑穩定性，並提供替代材料方案，從而解決有關塑化劑和萃取物的監管問題。與滅菌服務商、擠出專家和契約製造建立策略夥伴關係，能夠在維持資本效率的同時，實現快速規模化生產。

為業界領導者提供切實可行的優先建議，以最佳化採購、加強品管並加速一次性血袋技術的應用。

我們鼓勵產業領導者優先採取一系列切實可行的措施，以加強供應鏈，加速具有臨床意義的創新，並使採購決策與長期業務永續營運保持一致。首先，透過對多個地理位置分散的製造地進行資格認證，並檢驗第二供應商的組件，增加供應商多樣性，減少單點故障。其次，投資於材料和設計檢驗，以應對監管機構對可萃取物、生物相容性和滅菌可追溯性的關注，同時透過有針對性的可用性和血液相容性測試來證明其臨床益處。

透明的調查方法，包括資料來源、檢驗方法、相關人員訪談和分析框架的闡述，確保了研究結果的穩健性和可重複性。

本執行摘要的調查方法整合了對關鍵相關人員的訪談、技術文獻綜述、監管指南分析和供應鏈圖譜，以得出可靠且可重複的結論。主要資料來源包括對採購人員、血庫主任、臨床輸血專家和生產營運經理的結構化訪談，這些訪談深入了解了採購週期、檢驗要求和前置作業時間敏感度。次要資訊來源包括同行評審的臨床研究、材料安全資料、醫療設備監管文件和已發布的生產標準，這些資料為材料和設計權衡的技術評估提供了基礎。

結論部分全面總結了關鍵發現、策略意義以及不斷變化的臨床和供應鏈考量，這些因素將影響採購和創新的發展軌跡。

這些結論概括了一次性血袋生態系統中採購者、製造商和相關人員最重要的策略意義。材料創新、日益嚴格的病原體減少要求以及為應對政策和關稅壓力而進行的供應鏈重組，正在重塑該行業格局。因此，採購機構必須採用更全面的評估框架，對臨床適用性、生命週期性能、供應商韌性和合規準備進行同等評估。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：一次性血袋市場（依產品類型分類）

  • 血漿袋
    • 250毫升
    • 300毫升
    • 500毫升
  • 血小板袋
    • 病原體減少
    • 標準
  • 紅血球袋
    • 白血球去除
    • 非白血球分離術
  • 特殊用途袋
  • 全血袋
    • Cp2d
    • CpD
    • CPDA-1

第9章 按材料類型分類的一次性血袋市場

  • 不含聚氯乙烯
    • 聚烯
    • 矽酮
  • PVC

第10章：一次性血袋市場（依產品類型分類）

  • 雙層袋
  • 四重袋
  • 單袋
  • 米包

第11章 按應用分類的一次性血袋市場

  • 血液收集
  • 血液保存
  • 輸血
    • 緊急輸血
    • 定期輸血

第12章：按終端用戶分類的一次性血袋市場

  • 血庫
    • 私人的
    • 公共機構
  • 診所
  • 診斷中心
  • 醫院

第13章：各地區一次性血袋市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 一次性血袋市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 各國一次性血袋市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國一次性血袋市場

第17章：中國一次性血袋市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • 3S Corporation
  • BL Life Sciences Pvt. Ltd.
  • Becton, Dickinson and Company
  • Biolife Plasma Services, LP
  • Bionic Medizintechnik GmbH
  • Blue Neem Medical Devices Ltd.
  • CY Medical Co., Ltd.
  • Demophorius Healthcare
  • ERENLER MEDIKAL
  • Fresenius Kabi AG
  • General Cooperation Industry Co., Ltd.
  • Grifols, SA
  • Haemonetics Corporation
  • HLL Lifecare Limited
  • J. Mitra & Co. Pvt. Ltd.
  • Kawasumi Laboratories, Inc.
  • Lifecare Medical Innovation
  • Maco Pharma SAS
  • Mitra Industries Pvt. Ltd.
  • Mohini Health & Hygiene Ltd.
  • QED Kares Packers Pvt. Ltd.
Product Code: MRR-867BED9A9EC9

The Single Use Blood Bag Market was valued at USD 1.96 billion in 2025 and is projected to grow to USD 2.07 billion in 2026, with a CAGR of 6.57%, reaching USD 3.06 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.96 billion
Estimated Year [2026] USD 2.07 billion
Forecast Year [2032] USD 3.06 billion
CAGR (%) 6.57%

A concise but strategic introduction to single-use blood bag technologies, clinical imperatives, regulatory forces, and procurement priorities shaping provider decisions

This executive summary introduces the single-use blood bag sector by outlining the clinical imperatives, material science advances, and procurement priorities that currently steer purchasing decisions across healthcare systems. Over the past decade, clinicians and supply chain leaders have elevated priorities such as biocompatibility, pathogen mitigation, and handling ergonomics, which in turn influence product selection and supplier evaluations. Inflationary pressures on raw materials and logistical complexity have converged with clinical initiatives to reduce transfusion-related risks, creating a procurement environment that prizes traceability and validated quality controls.

As hospitals and blood services refine inventory management and regulatory compliance, single-use blood bag design and supplier credentials carry increased weight. Technological enhancements that reduce hemolysis, improve additive stability, and enable pathogen-reduction workflows are becoming differentiators rather than optional features. Consequently, procurement teams must balance unit cost with lifecycle performance, clinical outcomes, and vendor reliability. This introduction frames the subsequent analysis by highlighting how clinical needs, regulatory expectations, and operational realities combine to shape both short-term sourcing choices and longer-term strategic shifts in the sector.

Analytical overview of transformative shifts in single-use blood bag landscape including material innovations, pathogen-reduction trends, and supply chain resilience drivers

The landscape for single-use blood bags is undergoing transformative shifts driven by materials innovation, pathogen-reduction adoption, and a reorientation of global supply chains toward resilience. Advances in non-PVC polymer science and alternative sealing technologies have reduced concerns around plasticizers and enabled hospitals to meet stricter biocompatibility standards. Concurrently, pathogen-reduction systems and improvements in leukoreduction techniques have elevated requirements for bag compatibility, prompting manufacturers and contract producers to redesign fluid contact surfaces and tubing geometries.

Supply chain dynamics have also shifted: manufacturers increasingly pursue dual-source strategies, regionalized manufacturing, and qualified second-tier suppliers to mitigate geopolitical and logistical risk. Regulatory agencies are iterating guidance that tightens sterilization validation and material traceability, which in turn encourages investment in serialization and batch-level analytics. These convergent trends are reshaping product roadmaps and procurement evaluation criteria, so purchasers now evaluate not only unit performance but also supplier geography, quality infrastructure, and near-term capacity commitments when making sourcing decisions.

In-depth assessment of the cumulative effects of recent and pending United States tariffs on single-use blood bag supply chains, sourcing strategies, and clinical procurement

The cumulative impact of United States tariff actions implemented in 2025 has introduced new complexity to sourcing strategies for single-use blood bag components and finished goods. Tariffs on imported polymers, specialized tubing, and certain manufacturing equipment have increased landed costs for suppliers that rely on cross-border inputs, pushing many to reassess their supplier base and consider nearshoring or onshoring as risk mitigation. Procurement teams are responding by seeking longer-term agreements with tier-one suppliers and by incorporating tariff pass-through scenarios into contract negotiations.

Operationally, higher import duties have shortened planning horizons for distributors and hospitals, prompting some organizations to extend inventory horizons or qualify additional local manufacturers. In parallel, suppliers with diversified manufacturing footprints and in-region extrusion and assembly capabilities have gained negotiating leverage, enabling them to offer more stable lead times despite higher nominal costs. Policy uncertainty has also driven interest in tariff-minimizing strategies such as component substitution, redesign to use domestically available materials, and greater reliance on bonded warehousing to smooth cash flow implications. Ultimately, the tariffs have accelerated a broader shift toward supply chain diversification and increased emphasis on supplier transparency and compliance.

Segment-focused insights across product types, materials, configurations, end users, and applications that clarify clinical needs and procurement pathways in detail

Segmentation analysis reveals nuanced differences in clinical needs, manufacturing complexity, and procurement priorities across product types, materials, configurations, end users, and applications. Product type segmentation includes Plasma Bags, Platelet Bags, Red Cell Bags, Specialized Application Bags, and Whole Blood Bags; Plasma Bags are offered in 250 milliliter, 300 milliliter, and 500 milliliter formats, Platelet Bags are distinguished by pathogen reduction versus standard designs, Red Cell Bags separate leukoreduced from non-leukoreduced options, and Whole Blood Bags include CP2D, CPD, and CPDA-1 formulations. These distinctions drive distinct validation requirements, additive compatibility tests, and storage profile expectations.

Material type segmentation differentiates non-PVC and PVC constructions, with non-PVC options further divided into polyolefin and silicone-based materials. Each material pathway presents trade-offs in terms of elasticity, leachables profile, and weldability that influence both clinical handling and sterilization validation. Configuration segmentation covers double bag, quadruple bag, single bag, and triple bag systems, where additional bags enable more complex collection and processing workflows but increase manufacturing and sterilization complexity. End user segmentation spans blood banks, clinics, diagnostic centers, and hospitals, with blood banks further categorized as private or public institutions, each with distinct procurement cycles and inventory management paradigms. Finally, application segmentation encompasses blood collection, blood storage, and blood transfusion, with transfusion workflows subdivided into emergency transfusion and routine transfusion pathways. Understanding these layered segments is critical for tailoring product specifications, qualifying suppliers, and aligning inventory policies with clinical workflows.

Regional intelligence revealing demand dynamics, regulatory variations, and supply chain strengths across Americas, Europe Middle East & Africa, and Asia-Pacific markets

Regional dynamics shape regulatory expectations, supplier concentration, and sourcing strategies across the Americas, Europe Middle East & Africa, and Asia-Pacific regions. In the Americas, procurement emphasizes rapid response, regional manufacturing partnerships, and alignment with clinical networks that prioritize pathogen mitigation and traceability. Payment models and hospital group purchasing organizations influence contract structures and the degree to which total cost of ownership considerations drive adoption of premium features.

In Europe, Middle East & Africa, the regulatory environment and national blood service models create heterogeneity in approval pathways and product acceptance. Manufacturers targeting this region prioritize conformity with regional regulatory frameworks, extended shelf-life validation, and compatibility with diverse additive systems. In the Asia-Pacific region, rapid healthcare expansion and localized manufacturing capacity are producing both opportunity and competition. Demand growth in emerging markets is accelerating interest in cost-efficient configurations and modular bag systems suitable for decentralized blood collection, while advanced markets in the region prioritize compatibility with high-throughput automated processing equipment. Taken together, regional variations underscore the need for differentiated go-to-market strategies and local regulatory expertise.

Competitive landscape and company-level insights focusing on product portfolios, strategic partnerships, manufacturing footprints, and innovation trajectories in the sector

Company-level positioning within the single-use blood bag sector centers on product portfolio breadth, manufacturing footprint, partnership models, and innovation investment. Leading manufacturers are extending portfolios to support pathogen-reduction compatibility, enhanced additive stabilization, and alternative-material options that address regulatory concerns about plasticizers and extractables. Strategic partnerships with sterilization providers, extrusion specialists, and contract manufacturers enable faster scale-up while preserving capital efficiency.

Manufacturers with vertically integrated operations or regional assembly hubs have demonstrated advantages in lead-time reliability and tariff exposure management. At the same time, contract manufacturing organizations play a pivotal role in enabling new entrants and niche product developers to achieve regulatory compliance and production scale. Companies are also differentiating through enhanced quality management systems, investment in serialization and batch analytics, and clinical evidence generation that validates handling and performance claims. These competitive dynamics favor organizations that can combine robust quality infrastructure with flexible manufacturing capacity and targeted clinical support services.

Practical and prioritized recommendations for industry leaders to optimize sourcing, strengthen quality controls, and accelerate adoption of single-use blood bag technologies

Industry leaders should prioritize a set of actionable measures to fortify supply chains, accelerate clinically meaningful innovation, and align procurement decisions with long-term operational resilience. First, strengthen supplier diversification by qualifying multiple manufacturing sources across different geographies and validating second-source components to reduce single points of failure. Next, invest in materials and design validation that anticipate regulatory attention to leachables, biocompatibility, and sterilization traceability, while also demonstrating clinical benefit through targeted usability and hemocompatibility studies.

Further, adopt procurement practices that balance unit price with lifecycle costs by factoring in sterilization, storage, and clinical performance metrics. Build contractual flexibility with indexed pricing clauses or shared escalation mechanisms to absorb short-term tariff impacts while preserving supplier relationships. Enhance digital traceability through batch serialization and integrate quality analytics into supplier scorecards to enable proactive corrective actions. Finally, accelerate collaboration between clinical teams, blood services, and purchasing groups to pilot new configurations-such as pathogen-reduction-compatible platelet systems or non-PVC whole blood bags-in controlled settings prior to broad rollouts. These combined actions will drive measurable improvements in supply assurance and clinical outcome alignment.

Transparent research methodology explaining data sources, validation techniques, stakeholder interviews, and analytical frameworks used to ensure robustness and reproducibility

The research methodology underpinning this executive summary integrates primary stakeholder interviews, technical literature review, regulatory guidance analysis, and supply chain mapping to ensure robust, reproducible conclusions. Primary inputs include structured interviews with procurement leaders, blood bank directors, clinical transfusion experts, and manufacturing operations managers, which provided insight into purchasing cycles, validation requirements, and lead-time sensitivities. Secondary inputs encompass peer-reviewed clinical research, material safety data, device regulatory filings, and publicly available manufacturing standards that informed technical assessments of material and design trade-offs.

Analytical techniques included component-level risk assessment, scenario analysis for policy impacts, and triangulation of supplier capabilities with regional regulatory constraints. Data quality controls featured source triangulation, methodological transparency, and audit trails for interview transcripts and analytical assumptions. Wherever possible, findings were validated through cross-functional stakeholder review to ensure practical relevance and to reduce confirmation bias. This layered approach produces an evidence-based synthesis that balances clinical, regulatory, and operational perspectives.

Conclusive synthesis of core findings, strategic implications, and the evolving clinical and supply chain considerations that will influence procurement and innovation paths

This conclusion synthesizes the most salient strategic implications for purchasers, manufacturers, and policy stakeholders within the single-use blood bag ecosystem. The sector is being reshaped by material innovation, heightened pathogen-reduction imperatives, and supply chain realignment in response to policy and tariff pressures. Procurement organizations must therefore adopt more holistic evaluation frameworks that weigh clinical compatibility, lifecycle performance, supplier resilience, and compliance readiness in equal measure.

Manufacturers and contract producers that invest in validated alternative materials, regional capacity, and integrated quality data systems will be better positioned to meet evolving clinical and regulatory expectations. Simultaneously, coordinated planning between clinical services and supply chain teams can accelerate safe adoption of improved bag configurations while minimizing disruption to transfusion workflows. In short, resilience and clinical alignment-supported by rigorous supplier qualification and transparent traceability-will determine which strategies deliver sustainable competitive advantage in the years ahead.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Single Use Blood Bag Market, by Product Type

  • 8.1. Plasma Bags
    • 8.1.1. 250 Milliliter
    • 8.1.2. 300 Milliliter
    • 8.1.3. 500 Milliliter
  • 8.2. Platelet Bags
    • 8.2.1. Pathogen Reduction
    • 8.2.2. Standard
  • 8.3. Red Cell Bags
    • 8.3.1. Leukoreduced
    • 8.3.2. Non-Leukoreduced
  • 8.4. Specialized Application Bags
  • 8.5. Whole Blood Bags
    • 8.5.1. Cp2d
    • 8.5.2. Cpd
    • 8.5.3. Cpda-1

9. Single Use Blood Bag Market, by Material Type

  • 9.1. Non-Pvc
    • 9.1.1. Polyolefin
    • 9.1.2. Silicone
  • 9.2. Pvc

10. Single Use Blood Bag Market, by Configuration

  • 10.1. Double Bag
  • 10.2. Quadruple Bag
  • 10.3. Single Bag
  • 10.4. Triple Bag

11. Single Use Blood Bag Market, by Application

  • 11.1. Blood Collection
  • 11.2. Blood Storage
  • 11.3. Blood Transfusion
    • 11.3.1. Emergency Transfusion
    • 11.3.2. Routine Transfusion

12. Single Use Blood Bag Market, by End User

  • 12.1. Blood Banks
    • 12.1.1. Private
    • 12.1.2. Public
  • 12.2. Clinics
  • 12.3. Diagnostic Centers
  • 12.4. Hospitals

13. Single Use Blood Bag Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Single Use Blood Bag Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Single Use Blood Bag Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Single Use Blood Bag Market

17. China Single Use Blood Bag Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. 3S Corporation
  • 18.6. B.L. Life Sciences Pvt. Ltd.
  • 18.7. Becton, Dickinson and Company
  • 18.8. Biolife Plasma Services, L.P.
  • 18.9. Bionic Medizintechnik GmbH
  • 18.10. Blue Neem Medical Devices Ltd.
  • 18.11. C.Y. Medical Co., Ltd.
  • 18.12. Demophorius Healthcare
  • 18.13. ERENLER MEDIKAL
  • 18.14. Fresenius Kabi AG
  • 18.15. General Cooperation Industry Co., Ltd.
  • 18.16. Grifols, S.A.
  • 18.17. Haemonetics Corporation
  • 18.18. HLL Lifecare Limited
  • 18.19. J. Mitra & Co. Pvt. Ltd.
  • 18.20. Kawasumi Laboratories, Inc.
  • 18.21. Lifecare Medical Innovation
  • 18.22. Maco Pharma S.A.S.
  • 18.23. Mitra Industries Pvt. Ltd.
  • 18.24. Mohini Health & Hygiene Ltd.
  • 18.25. QED Kares Packers Pvt. Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL SINGLE USE BLOOD BAG MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL SINGLE USE BLOOD BAG MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY CONFIGURATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES SINGLE USE BLOOD BAG MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA SINGLE USE BLOOD BAG MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY PLASMA BAGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY PLASMA BAGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY PLASMA BAGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY PLASMA BAGS, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY 250 MILLILITER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY 250 MILLILITER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY 250 MILLILITER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY 300 MILLILITER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY 300 MILLILITER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY 300 MILLILITER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY 500 MILLILITER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY 500 MILLILITER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY 500 MILLILITER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY PLATELET BAGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY PLATELET BAGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY PLATELET BAGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY PLATELET BAGS, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY PATHOGEN REDUCTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY PATHOGEN REDUCTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY PATHOGEN REDUCTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY STANDARD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY STANDARD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY STANDARD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY RED CELL BAGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY RED CELL BAGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY RED CELL BAGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY RED CELL BAGS, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY LEUKOREDUCED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY LEUKOREDUCED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY LEUKOREDUCED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY NON-LEUKOREDUCED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY NON-LEUKOREDUCED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY NON-LEUKOREDUCED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY SPECIALIZED APPLICATION BAGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY SPECIALIZED APPLICATION BAGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY SPECIALIZED APPLICATION BAGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY WHOLE BLOOD BAGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY WHOLE BLOOD BAGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY WHOLE BLOOD BAGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY WHOLE BLOOD BAGS, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY CP2D, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY CP2D, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY CP2D, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY CPD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY CPD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY CPD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY CPDA-1, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY CPDA-1, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY CPDA-1, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY NON-PVC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY NON-PVC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY NON-PVC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY POLYOLEFIN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY POLYOLEFIN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY POLYOLEFIN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY SILICONE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY SILICONE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY SILICONE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY PVC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY PVC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY PVC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY DOUBLE BAG, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY DOUBLE BAG, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY DOUBLE BAG, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY QUADRUPLE BAG, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY QUADRUPLE BAG, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY QUADRUPLE BAG, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY SINGLE BAG, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY SINGLE BAG, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY SINGLE BAG, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY TRIPLE BAG, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY TRIPLE BAG, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY TRIPLE BAG, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY BLOOD COLLECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY BLOOD COLLECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY BLOOD COLLECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY BLOOD STORAGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY BLOOD STORAGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY BLOOD STORAGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY BLOOD TRANSFUSION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY BLOOD TRANSFUSION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY BLOOD TRANSFUSION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY BLOOD TRANSFUSION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY EMERGENCY TRANSFUSION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY EMERGENCY TRANSFUSION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY EMERGENCY TRANSFUSION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY ROUTINE TRANSFUSION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY ROUTINE TRANSFUSION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY ROUTINE TRANSFUSION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY BLOOD BANKS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY BLOOD BANKS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY BLOOD BANKS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY BLOOD BANKS, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY PRIVATE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY PRIVATE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY PRIVATE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY PUBLIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY PUBLIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY PUBLIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 117. AMERICAS SINGLE USE BLOOD BAG MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 118. AMERICAS SINGLE USE BLOOD BAG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. AMERICAS SINGLE USE BLOOD BAG MARKET SIZE, BY PLASMA BAGS, 2018-2032 (USD MILLION)
  • TABLE 120. AMERICAS SINGLE USE BLOOD BAG MARKET SIZE, BY PLATELET BAGS, 2018-2032 (USD MILLION)
  • TABLE 121. AMERICAS SINGLE USE BLOOD BAG MARKET SIZE, BY RED CELL BAGS, 2018-2032 (USD MILLION)
  • TABLE 122. AMERICAS SINGLE USE BLOOD BAG MARKET SIZE, BY WHOLE BLOOD BAGS, 2018-2032 (USD MILLION)
  • TABLE 123. AMERICAS SINGLE USE BLOOD BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 124. AMERICAS SINGLE USE BLOOD BAG MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 125. AMERICAS SINGLE USE BLOOD BAG MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 126. AMERICAS SINGLE USE BLOOD BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 127. AMERICAS SINGLE USE BLOOD BAG MARKET SIZE, BY BLOOD TRANSFUSION, 2018-2032 (USD MILLION)
  • TABLE 128. AMERICAS SINGLE USE BLOOD BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 129. AMERICAS SINGLE USE BLOOD BAG MARKET SIZE, BY BLOOD BANKS, 2018-2032 (USD MILLION)
  • TABLE 130. NORTH AMERICA SINGLE USE BLOOD BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 131. NORTH AMERICA SINGLE USE BLOOD BAG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 132. NORTH AMERICA SINGLE USE BLOOD BAG MARKET SIZE, BY PLASMA BAGS, 2018-2032 (USD MILLION)
  • TABLE 133. NORTH AMERICA SINGLE USE BLOOD BAG MARKET SIZE, BY PLATELET BAGS, 2018-2032 (USD MILLION)
  • TABLE 134. NORTH AMERICA SINGLE USE BLOOD BAG MARKET SIZE, BY RED CELL BAGS, 2018-2032 (USD MILLION)
  • TABLE 135. NORTH AMERICA SINGLE USE BLOOD BAG MARKET SIZE, BY WHOLE BLOOD BAGS, 2018-2032 (USD MILLION)
  • TABLE 136. NORTH AMERICA SINGLE USE BLOOD BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. NORTH AMERICA SINGLE USE BLOOD BAG MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 138. NORTH AMERICA SINGLE USE BLOOD BAG MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 139. NORTH AMERICA SINGLE USE BLOOD BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 140. NORTH AMERICA SINGLE USE BLOOD BAG MARKET SIZE, BY BLOOD TRANSFUSION, 2018-2032 (USD MILLION)
  • TABLE 141. NORTH AMERICA SINGLE USE BLOOD BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 142. NORTH AMERICA SINGLE USE BLOOD BAG MARKET SIZE, BY BLOOD BANKS, 2018-2032 (USD MILLION)
  • TABLE 143. LATIN AMERICA SINGLE USE BLOOD BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. LATIN AMERICA SINGLE USE BLOOD BAG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. LATIN AMERICA SINGLE USE BLOOD BAG MARKET SIZE, BY PLASMA BAGS, 2018-2032 (USD MILLION)
  • TABLE 146. LATIN AMERICA SINGLE USE BLOOD BAG MARKET SIZE, BY PLATELET BAGS, 2018-2032 (USD MILLION)
  • TABLE 147. LATIN AMERICA SINGLE USE BLOOD BAG MARKET SIZE, BY RED CELL BAGS, 2018-2032 (USD MILLION)
  • TABLE 148. LATIN AMERICA SINGLE USE BLOOD BAG MARKET SIZE, BY WHOLE BLOOD BAGS, 2018-2032 (USD MILLION)
  • TABLE 149. LATIN AMERICA SINGLE USE BLOOD BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 150. LATIN AMERICA SINGLE USE BLOOD BAG MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 151. LATIN AMERICA SINGLE USE BLOOD BAG MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 152. LATIN AMERICA SINGLE USE BLOOD BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 153. LATIN AMERICA SINGLE USE BLOOD BAG MARKET SIZE, BY BLOOD TRANSFUSION, 2018-2032 (USD MILLION)
  • TABLE 154. LATIN AMERICA SINGLE USE BLOOD BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 155. LATIN AMERICA SINGLE USE BLOOD BAG MARKET SIZE, BY BLOOD BANKS, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA SINGLE USE BLOOD BAG MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA SINGLE USE BLOOD BAG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE, MIDDLE EAST & AFRICA SINGLE USE BLOOD BAG MARKET SIZE, BY PLASMA BAGS, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE, MIDDLE EAST & AFRICA SINGLE USE BLOOD BAG MARKET SIZE, BY PLATELET BAGS, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE, MIDDLE EAST & AFRICA SINGLE USE BLOOD BAG MARKET SIZE, BY RED CELL BAGS, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPE, MIDDLE EAST & AFRICA SINGLE USE BLOOD BAG MARKET SIZE, BY WHOLE BLOOD BAGS, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPE, MIDDLE EAST & AFRICA SINGLE USE BLOOD BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPE, MIDDLE EAST & AFRICA SINGLE USE BLOOD BAG MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPE, MIDDLE EAST & AFRICA SINGLE USE BLOOD BAG MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPE, MIDDLE EAST & AFRICA SINGLE USE BLOOD BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPE, MIDDLE EAST & AFRICA SINGLE USE BLOOD BAG MARKET SIZE, BY BLOOD TRANSFUSION, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPE, MIDDLE EAST & AFRICA SINGLE USE BLOOD BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPE, MIDDLE EAST & AFRICA SINGLE USE BLOOD BAG MARKET SIZE, BY BLOOD BANKS, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPE SINGLE USE BLOOD BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPE SINGLE USE BLOOD BAG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 171. EUROPE SINGLE USE BLOOD BAG MARKET SIZE, BY PLASMA BAGS, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPE SINGLE USE BLOOD BAG MARKET SIZE, BY PLATELET BAGS, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPE SINGLE USE BLOOD BAG MARKET SIZE, BY RED CELL BAGS, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPE SINGLE USE BLOOD BAG MARKET SIZE, BY WHOLE BLOOD BAGS, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPE SINGLE USE BLOOD BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPE SINGLE USE BLOOD BAG MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPE SINGLE USE BLOOD BAG MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPE SINGLE USE BLOOD BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPE SINGLE USE BLOOD BAG MARKET SIZE, BY BLOOD TRANSFUSION, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPE SINGLE USE BLOOD BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPE SINGLE USE BLOOD BAG MARKET SIZE, BY BLOOD BANKS, 2018-2032 (USD MILLION)
  • TABLE 182. MIDDLE EAST SINGLE USE BLOOD BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 183. MIDDLE EAST SINGLE USE BLOOD BAG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 184. MIDDLE EAST SINGLE USE BLOOD BAG MARKET SIZE, BY PLASMA BAGS, 2018-2032 (USD MILLION)
  • TABLE 185. MIDDLE EAST SINGLE USE BLOOD BAG MARKET SIZE, BY PLATELET BAGS, 2018-2032 (USD MILLION)
  • TABLE 186. MIDDLE EAST SINGLE USE BLOOD BAG MARKET SIZE, BY RED CELL BAGS, 2018-2032 (USD MILLION)
  • TABLE 187. MIDDLE EAST SINGLE USE BLOOD BAG MARKET SIZE, BY WHOLE BLOOD BAGS, 2018-2032 (USD MILLION)
  • TABLE 188. MIDDLE EAST SINGLE USE BLOOD BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 189. MIDDLE EAST SINGLE USE BLOOD BAG MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 190. MIDDLE EAST SINGLE USE BLOOD BAG MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 191. MIDDLE EAST SINGLE USE BLOOD BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 192. MIDDLE EAST SINGLE USE BLOOD BAG MARKET SIZE, BY BLOOD TRANSFUSION, 2018-2032 (USD MILLION)
  • TABLE 193. MIDDLE EAST SINGLE USE BLOOD BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 194. MIDDLE EAST SINGLE USE BLOOD BAG MARKET SIZE, BY BLOOD BANKS, 2018-2032 (USD MILLION)
  • TABLE 195. AFRICA SINGLE USE BLOOD BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 196. AFRICA SINGLE USE BLOOD BAG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 197. AFRICA SINGLE USE BLOOD BAG MARKET SIZE, BY PLASMA BAGS, 2018-2032 (USD MILLION)
  • TABLE 198. AFRICA SINGLE USE BLOOD BAG MARKET SIZE, BY PLATELET BAGS, 2018-2032 (USD MILLION)
  • TABLE 199. AFRICA SINGLE USE BLOOD BAG MARKET SIZE, BY RED CELL BAGS, 2018-2032 (USD MILLION)
  • TABLE 200. AFRICA SINGLE USE BLOOD BAG MARKET SIZE, BY WHOLE BLOOD BAGS, 2018-2032 (USD MILLION)
  • TABLE 201. AFRICA SINGLE USE BLOOD BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 202. AFRICA SINGLE USE BLOOD BAG MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 203. AFRICA SINGLE USE BLOOD BAG MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 204. AFRICA SINGLE USE BLOOD BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 205. AFRICA SINGLE USE BLOOD BAG MARKET SIZE, BY BLOOD TRANSFUSION, 2018-2032 (USD MILLION)
  • TABLE 206. AFRICA SINGLE USE BLOOD BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 207. AFRICA SINGLE USE BLOOD BAG MARKET SIZE, BY BLOOD BANKS, 2018-2032 (USD MILLION)
  • TABLE 208. ASIA-PACIFIC SINGLE USE BLOOD BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 209. ASIA-PACIFIC SINGLE USE BLOOD BAG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 210. ASIA-PACIFIC SINGLE USE BLOOD BAG MARKET SIZE, BY PLASMA BAGS, 2018-2032 (USD MILLION)
  • TABLE 211. ASIA-PACIFIC SINGLE USE BLOOD BAG MARKET SIZE, BY PLATELET BAGS, 2018-2032 (USD MILLION)
  • TABLE 212. ASIA-PACIFIC SINGLE USE BLOOD BAG MARKET SIZE, BY RED CELL BAGS, 2018-2032 (USD MILLION)
  • TABLE 213. ASIA-PACIFIC SINGLE USE BLOOD BAG MARKET SIZE, BY WHOLE BLOOD BAGS, 2018-2032 (USD MILLION)
  • TABLE 214. ASIA-PACIFIC SINGLE USE BLOOD BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 215. ASIA-PACIFIC SINGLE USE BLOOD BAG MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 216. ASIA-PACIFIC SINGLE USE BLOOD BAG MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 217. ASIA-PACIFIC SINGLE USE BLOOD BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 218. ASIA-PACIFIC SINGLE USE BLOOD BAG MARKET SIZE, BY BLOOD TRANSFUSION, 2018-2032 (USD MILLION)
  • TABLE 219. ASIA-PACIFIC SINGLE USE BLOOD BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 220. ASIA-PACIFIC SINGLE USE BLOOD BAG MARKET SIZE, BY BLOOD BANKS, 2018-2032 (USD MILLION)
  • TABLE 221. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 222. ASEAN SINGLE USE BLOOD BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 223. ASEAN SINGLE USE BLOOD BAG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 224. ASEAN SINGLE USE BLOOD BAG MARKET SIZE, BY PLASMA BAGS, 2018-2032 (USD MILLION)
  • TABLE 225. ASEAN SINGLE USE BLOOD BAG MARKET SIZE, BY PLATELET BAGS, 2018-2032 (USD MILLION)
  • TABLE 226. ASEAN SINGLE USE BLOOD BAG MARKET SIZE, BY RED CELL BAGS, 2018-2032 (USD MILLION)
  • TABLE 227. ASEAN SINGLE USE BLOOD BAG MARKET SIZE, BY WHOLE BLOOD BAGS, 2018-2032 (USD MILLION)
  • TABLE 228. ASEAN SINGLE USE BLOOD BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 229. ASEAN SINGLE USE BLOOD BAG MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 230. ASEAN SINGLE USE BLOOD BAG MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 231. ASEAN SINGLE USE BLOOD BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 232. ASEAN SINGLE USE BLOOD BAG MARKET SIZE, BY BLOOD TRANSFUSION, 2018-2032 (USD MILLION)
  • TABLE 233. ASEAN SINGLE USE BLOOD BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 234. ASEAN SINGLE USE BLOOD BAG MARKET SIZE, BY BLOOD BANKS, 2018-2032 (USD MILLION)
  • TABLE 235. GCC SINGLE USE BLOOD BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 236. GCC SINGLE USE BLOOD BAG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 237. GCC SINGLE USE BLOOD BAG MARKET SIZE, BY PLASMA BAGS, 2018-2032 (USD MILLION)
  • TABLE 238. GCC SINGLE USE BLOOD BAG MARKET SIZE, BY PLATELET BAGS, 2018-2032 (USD MILLION)
  • TABLE 239. GCC SINGLE USE BLOOD BAG MARKET SIZE, BY RED CELL BAGS, 2018-2032 (USD MILLION)
  • TABLE 240. GCC SINGLE USE BLOOD BAG MARKET SIZE, BY WHOLE BLOOD BAGS, 2018-2032 (USD MILLION)
  • TABLE 241. GCC SINGLE USE BLOOD BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 242. GCC SINGLE USE BLOOD BAG MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 243. GCC SINGLE USE BLOOD BAG MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 244. GCC SINGLE USE BLOOD BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 245. GCC SINGLE USE BLOOD BAG MARKET SIZE, BY BLOOD TRANSFUSION, 2018-2032 (USD MILLION)
  • TABLE 246. GCC SINGLE USE BLOOD BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 247. GCC SINGLE USE BLOOD BAG MARKET SIZE, BY BLOOD BANKS, 2018-2032 (USD MILLION)
  • TABLE 248. EUROPEAN UNION SINGLE USE BLOOD BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 249. EUROPEAN UNION SINGLE USE BLOOD BAG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 250. EUROPEAN UNION SINGLE USE BLOOD BAG MARKET SIZE, BY PLASMA BAGS, 2018-2032 (USD MILLION)
  • TABLE 251. EUROPEAN UNION SINGLE USE BLOOD BAG MARKET SIZE, BY PLATELET BAGS, 2018-2032 (USD MILLION)
  • TABLE 252. EUROPEAN UNION SINGLE USE BLOOD BAG MARKET SIZE, BY RED CELL BAGS, 2018-2032 (USD MILLION)
  • TABLE 253. EUROPEAN UNION SINGLE USE BLOOD BAG MARKET SIZE, BY WHOLE BLOOD BAGS, 2018-2032 (USD MILLION)
  • TABLE 254. EUROPEAN UNION SINGLE USE BLOOD BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 255. EUROPEAN UNION SINGLE USE BLOOD BAG MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 256. EUROPEAN UNION SINGLE USE BLOOD BAG MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 257. EUROPEAN UNION SINGLE USE BLOOD BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 258. EUROPEAN UNION SINGLE USE BLOOD BAG MARKET SIZE, BY BLOOD TRANSFUSION, 2018-2032 (USD MILLION)
  • TABLE 259. EUROPEAN UNION SINGLE USE BLOOD BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 260. EUROPEAN UNION SINGLE USE BLOOD BAG MARKET SIZE, BY BLOOD BANKS, 2018-2032 (USD MILLION)
  • TABLE 261. BRICS SINGLE USE BLOOD BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 262. BRICS SINGLE USE BLOOD BAG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 263. BRICS SINGLE USE BLOOD BAG MARKET SIZE, BY PLASMA BAGS, 2018-2032 (USD MILLION)
  • TABLE 264. BRICS SINGLE USE BLOOD BAG MARKET SIZE, BY PLATELET BAGS, 2018-2032 (USD MILLION)
  • TABLE 265. BRICS SINGLE USE BLOOD BAG MARKET SIZE, BY RED CELL BAGS, 2018-2032 (USD MILLION)
  • TABLE 266. BRICS SINGLE USE BLOOD BAG MARKET SIZE, BY WHOLE BLOOD BAGS, 2018-2032 (USD MILLION)
  • TABLE 267. BRICS SINGLE USE BLOOD BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 268. BRICS SINGLE USE BLOOD BAG MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 269. BRICS SINGLE USE BLOOD BAG MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 270. BRICS SINGLE USE BLOOD BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 271. BRICS SINGLE USE BLOOD BAG MARKET SIZE, BY BLOOD TRANSFUSION, 2018-2032 (USD MILLION)
  • TABLE 272. BRICS SINGLE USE BLOOD BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 273. BRICS SINGLE USE BLOOD BAG MARKET SIZE, BY BLOOD BANKS, 2018-2032 (USD MILLION)
  • TABLE 274. G7 SINGLE USE BLOOD BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 275. G7 SINGLE USE BLOOD BAG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 276. G7 SINGLE USE BLOOD BAG MARKET SIZE, BY PLASMA BAGS, 2018-2032 (USD MILLION)
  • TABLE 277. G7 SINGLE USE BLOOD BAG MARKET SIZE, BY PLATELET BAGS, 2018-2032 (USD MILLION)
  • TABLE 278. G7 SINGLE USE BLOOD BAG MARKET SIZE, BY RED CELL BAGS, 2018-2032 (USD MILLION)
  • TABLE 279. G7 SINGLE USE BLOOD BAG MARKET SIZE, BY WHOLE BLOOD BAGS, 2018-2032 (USD MILLION)
  • TABLE 280. G7 SINGLE USE BLOOD BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 281. G7 SINGLE USE BLOOD BAG MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 282. G7 SINGLE USE BLOOD BAG MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 283. G7 SINGLE USE BLOOD BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 284. G7 SINGLE USE BLOOD BAG MARKET SIZE, BY BLOOD TRANSFUSION, 2018-2032 (USD MILLION)
  • TABLE 285. G7 SINGLE USE BLOOD BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 286. G7 SINGLE USE BLOOD BAG MARKET SIZE, BY BLOOD BANKS, 2018-2032 (USD MILLION)
  • TABLE 287. NATO SINGLE USE BLOOD BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 288. NATO SINGLE USE BLOOD BAG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 289. NATO SINGLE USE BLOOD BAG MARKET SIZE, BY PLASMA BAGS, 2018-2032 (USD MILLION)
  • TABLE 290. NATO SINGLE USE BLOOD BAG MARKET SIZE, BY PLATELET BAGS, 2018-2032 (USD MILLION)
  • TABLE 291. NATO SINGLE USE BLOOD BAG MARKET SIZE, BY RED CELL BAGS, 2018-2032 (USD MILLION)
  • TABLE 292. NATO SINGLE USE BLOOD BAG MARKET SIZE, BY WHOLE BLOOD BAGS, 2018-2032 (USD MILLION)
  • TABLE 293. NATO SINGLE USE BLOOD BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 294. NATO SINGLE USE BLOOD BAG MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 295. NATO SINGLE USE BLOOD BAG MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 296. NATO SINGLE USE BLOOD BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 297. NATO SINGLE USE BLOOD BAG MARKET SIZE, BY BLOOD TRANSFUSION, 2018-2032 (USD MILLION)
  • TABLE 298. NATO SINGLE USE BLOOD BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 299. NATO SINGLE USE BLOOD BAG MARKET SIZE, BY BLOOD BANKS, 2018-2032 (USD MILLION)
  • TABLE 300. GLOBAL SINGLE USE BLOOD BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 301. UNITED STATES SINGLE USE BLOOD BAG MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 302. UNITED STATES SINGLE USE BLOOD BAG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 303. UNITED STATES SINGLE USE BLOOD BAG MARKET SIZE, BY PLASMA BAGS, 2018-2032 (USD MILLION)
  • TABLE 304. UNITED STATES SINGLE USE BLOOD BAG MARKET SIZE, BY PLATELET BAGS, 2018-2032 (USD MILLION)
  • TABLE 305. UNITED STATES SINGLE USE BLOOD BAG MARKET SIZE, BY RED CELL BAGS, 2018-2032 (USD MILLION)
  • TABLE 306. UNITED STATES SINGLE USE BLOOD BAG MARKET SIZE, BY WHOLE BLOOD BAGS, 2018-2032 (USD MILLION)
  • TABLE 307. UNITED STATES SINGLE USE BLOOD BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 308. UNITED STATES SINGLE USE BLOOD BAG MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 309. UNITED STATES SINGLE USE BLOOD BAG MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 310. UNITED STATES SINGLE USE BLOOD BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 311. UNITED STATES SINGLE USE BLOOD BAG MARKET SIZE, BY BLOOD TRANSFUSION, 2018-2032 (USD MILLION)
  • TABLE 312. UNITED STATES SINGLE USE BLOOD BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 313. UNITED STATES SINGLE USE BLOOD BAG MARKET SIZE, BY BLOOD BANKS, 2018-2032 (USD MILLION)
  • TABLE 314. CHINA SINGLE USE BLOOD BAG MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 315. CHINA SINGLE USE BLOOD BAG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 316. CHINA SINGLE USE BLOOD BAG MARKET SIZE, BY PLASMA BAGS, 2018-2032 (USD MILLION)
  • TABLE 317. CHINA SINGLE USE BLOOD BAG MARKET SIZE, BY PLATELET BAGS, 2018-2032 (USD MILLION)
  • TABLE 318. CHINA SINGLE USE BLOOD BAG MARKET SIZE, BY RED CELL BAGS, 2018-2032 (USD MILLION)
  • TABLE 319. CHINA SINGLE USE BLOOD BAG MARKET SIZE, BY WHOLE BLOOD BAGS, 2018-2032 (USD MILLION)
  • TABLE 320. CHINA SINGLE USE BLOOD BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 321. CHINA SINGLE USE BLOOD BAG MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 322. CHINA SINGLE USE BLOOD BAG MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 323. CHINA SINGLE USE BLOOD BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 324. CHINA SINGLE USE BLOOD BAG MARKET SIZE, BY BLOOD TRANSFUSION, 2018-2032 (USD MILLION)
  • TABLE 325. CHINA SINGLE USE BLOOD BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 326. CHINA SINGLE USE BLOOD BAG MARKET SIZE, BY BLOOD BANKS, 2018-2032 (USD MILLION)